Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,604 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Interleukin-4-Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy.
Kawakami M, Kawakami K, Puri RK. Kawakami M, et al. Among authors: kawakami k. J Neurooncol. 2003 Oct;65(1):15-25. doi: 10.1023/a:1026294416718. J Neurooncol. 2003. PMID: 14649882 Review.
Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.
Kioi M, Kawakami M, Shimamura T, Husain SR, Puri RK. Kioi M, et al. Among authors: kawakami m. Cancer. 2006 Sep 15;107(6):1407-18. doi: 10.1002/cncr.22134. Cancer. 2006. PMID: 16902988
Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chain.
Kawakami K, Terabe M, Kawakami M, Berzofsky JA, Puri RK. Kawakami K, et al. Among authors: kawakami m. Cancer Res. 2006 Apr 15;66(8):4434-42. doi: 10.1158/0008-5472.CAN-05-1265. Cancer Res. 2006. PMID: 16618770
Expression and targeting of interleukin-4 receptor for primary and advanced ovarian cancer therapy.
Kioi M, Takahashi S, Kawakami M, Kawakami K, Kreitman RJ, Puri RK. Kioi M, et al. Among authors: kawakami m, kawakami k. Cancer Res. 2005 Sep 15;65(18):8388-96. doi: 10.1158/0008-5472.CAN-05-1043. Cancer Res. 2005. PMID: 16166317
Combined effects of radiation and interleukin-13 receptor-targeted cytotoxin on glioblastoma cell lines.
Kawakami K, Kawakami M, Liu Q, Puri RK. Kawakami K, et al. Among authors: kawakami m. Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):230-7. doi: 10.1016/j.ijrobp.2005.05.017. Int J Radiat Oncol Biol Phys. 2005. PMID: 16111594
Evidence that IL-13R alpha2 chain in human glioma cells is responsible for the antitumor activity mediated by receptor-directed cytotoxin therapy.
Kawakami K, Kioi M, Liu Q, Kawakami M, Puri RK. Kawakami K, et al. Among authors: kawakami m. J Immunother. 2005 May-Jun;28(3):193-202. doi: 10.1097/01.cji.0000161393.04207.e1. J Immunother. 2005. PMID: 15838375
Hodgkin lymphoma therapy with interleukin-4 receptor-directed cytotoxin in an infiltrating animal model.
Kawakami M, Kawakami K, Kioi M, Leland P, Puri RK. Kawakami M, et al. Among authors: kawakami k. Blood. 2005 May 1;105(9):3707-13. doi: 10.1182/blood-2004-08-3216. Epub 2004 Dec 30. Blood. 2005. PMID: 15626735 Free PMC article.
Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine model.
Kawakami K, Kawakami M, Kioi M, Husain SR, Puri RK. Kawakami K, et al. Among authors: kawakami m. J Neurosurg. 2004 Dec;101(6):1004-11. doi: 10.3171/jns.2004.101.6.1004. J Neurosurg. 2004. PMID: 15597761
Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors.
Kawakami M, Kawakami K, Takahashi S, Abe M, Puri RK. Kawakami M, et al. Among authors: kawakami k. Cancer. 2004 Sep 1;101(5):1036-42. doi: 10.1002/cncr.20470. Cancer. 2004. PMID: 15329913
Nitric oxide accelerates interleukin-13 cytotoxin-mediated regression in head and neck cancer animal model.
Kawakami K, Kawakami M, Puri RK. Kawakami K, et al. Among authors: kawakami m. Clin Cancer Res. 2004 Aug 1;10(15):5264-70. doi: 10.1158/1078-0432.CCR-04-0314. Clin Cancer Res. 2004. PMID: 15297430
1,604 results
Jump to page
Feedback